In this study, we used the CanPatrol CTC enrichment technique, which has been applied for a broad range of carcinomas based on epithelial and mesenchymal markers (20–24), to detect the CTC level and to investigate the clinical significance of CTCs undergoing EMT in omHSPC patients treated with CRP. This evidence concerns the gene CRP and carcinoma.